Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Burkitt LymphomaRetinoblastomaDiffuse Large B-cell Lymphoma
Interventions
OTHER

mNavigator

Allied health providers at BMC will use mNavigator to facilitate compliance with protocol-driven treatment and reduce patient abandonment for patients diagnosed with Burkitt lymphoma, Diffuse large B-cell lymphoma or retinoblastoma.

Trial Locations (1)

Unknown

Bugando Medical Centre, Mwanza

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER